• 

  August 24, 2025

  Precision Cancer Medicines for Colon Cancer

  Charles H. Weaver, MD

• 

  July 26, 2025

  Precision Cancer Medicines and Breast Cancer

  Charles H. Weaver, MD

• 

  August 31, 2023

  Patritumab Deruxtecan Shows Promise in HER3-Expressing Metastatic Breast Cancer

  Charles H. Weaver, MD

• 

  May 7, 2022

  Understanding Your Breast Pathology Report

  Charles H. Weaver, MD

• 

  February 9, 2022

  Precision Cancer Medicines for Endometrial Cancer

  Charles H. Weaver, MD

• 

  February 2, 2021

  Precision Cancer Medicines & Immunotherapy for Lung Cancer

  Charles H. Weaver, MD

• 

  January 15, 2021

  HER2, Herceptin and Precision Cancer Medicines Targeting Gastric Cancer

  Charles H. Weaver, MD

• 

  November 26, 2020

  Treatment of Stage IV – Metastatic Pancreatic Cancer

  Charles H. Weaver, MD

• 

  September 23, 2020

  Treatment of Stage IV Esophageal Cancer

  Charles H. Weaver, MD

• 

  August 28, 2020

  Treatment of Stage IV Bladder Cancer

  Charles H. Weaver, MD

• 

  June 5, 2020

  Tukysa (tucatinib) – HER2 Inhibitor for Treatment of Breast Cancer

  Charles H. Weaver, MD

• 

  December 17, 2019

  Kadcyla (T-DM1) Significantly Improves Treatment of HER 2 + Breast Cancers

  Charles H. Weaver, MD